The Effect of Gonadotropin-releasing Hormone Analog Treatment on Body Mass Index and Height in Female Patients with Central Precocious Puberty
Aim:Gonadotropin-releasing hormone agonists (GnRHa) are widely used in the treatment of central precocious puberty (CPP). There is concern that GnRHa treatment, whose positive effects on the adult height are known, may cause weight gain and body mass index (BMI) increase. The aim of this study was t...
Saved in:
Main Authors: | Muammer Büyükinan (Author), Hüseyin Kurku (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayinevi,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
by: Jadranka Popovic, et al.
Published: (2022) -
Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
by: Eun Young Kim
Published: (2015) -
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014) -
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023) -
Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
by: Eren Er, et al.
Published: (2023)